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Abstract The aim of this study is to encapsulate two
drugs: 5-fluorouracil (5-FU) with the hydrophobic proper-
ties and 1-b-D-arabinofuranosylcytosine (Ara-C) with the
amphiphilic properties into liposomes prepared by the
modified reverse-phase evaporation method (mREV) from
L-a-phosphatidylcholine dipalmitoyl (DPPC). We studied
the thermotropic phase behavior of liposome entrapped
5-FU and Ara-C. It is known that the stability of liposomes
depends not only on the method of chemical gradient
loading, the use of membrane stabilizer such as sterols, but
also on the phase transition temperature (Tc) of phospho-
lipids, which undergoes an alteration after encapsulation of
drugs to liposomes. The competition of these two drugs
entrapped in liposomes was analyzed by the use of two
spectroscopies: 1H NMR and UV on the basis of the
analysis of the signals of each drug in the liposome—drug
system. The percent of encapsulation in DPPC/Ara-C/5-FU
liposome obtained by the use of UV spectroscopy
amounted 93.84 and 96.05% for 5-FU and Ara-C, respec-
tively. Phase transition temperature Tc of liposomes con-
taining Ara-C did not significantly change while for the
liposomes containing 5-FU it increased in comparison with
Tc of the reference liposomes formed from DPPC.
Keywords Liposome  Multidrug therapy  mREV 
NMR  UV
Introduction
Liposomes, vesicles enclosing an aqueous solution with
membranes of phospholipids, have been extensively stud-
ied as microparticulate carriers for the efficient delivery of
therapeutic agents since the first report by Bangham et al.
[1]. The superiority of liposomes as drug carriers is now
widely recognized and great advances in the liposome field
have resulted in the development of some approved lipo-
somal products [2]. However, it is still not easy to prepare
acceptable aseptic liposomal drugs with desirable proper-
ties, high encapsulation efficiency, and long-term stability
without drug leakage and loss [3]. When liposomes are
used as drug carriers, their size is of major importance,
since this influences the behavior of liposomes in biologi-
cal systems [4, 5].
Many efforts have been made to improve the properties
of liposomal preparations, especially the encapsulation
efficiency, vesicle size, and stability, which are still major
problems standing in the way of new advances in this field.
Up to now, a number of different methods has been suc-
cessfully developed for the preparation of liposomes. These
methods can be classified for convenience into three cate-
gories based on the dispersion technology: (1) mechanical
dispersion methods, for example, hand shaking, or vor-
texing, sonication, and the use of a French press; (2)
detergent-solubilizing dispersion methods including solu-
bilizing lecithin with sodium cholate or octylglucoside; (3)
solvent dispersion methods, such as ethanol injection, ether
infusion, and reverse-phase evaporation (REV). Liposomes
prepared by the REV method are known to have a higher
encapsulation efficiency for water-soluble agents than
those prepared by other methods [6].
In this report, we have presented the small liposomes
prepared by the modified REV method [7] with the
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desirable properties of the relatively high encapsulation
efficiency of antitumor drugs Ara-C and 5-FU and a mean
diameter less than 100 nm [5]. The drugs are used in the
anticancer multidrug therapy F-MACHOP (fluorouracil,
methotrexate, Ara-C, cyclophosphamide, doxorubicin,
vincristine, and prednisone).
For liposomes used in the analytical and bioanalytical
applications, the main characteristics include the encapsu-
lation efficiency, the ratio of phospholipids to encapsulant
concentration, and the temperature of phase transition (Tc).
When lipid bilayers prepared from pure one-component
phospholipids are subjected to heating under the ambient
pressure condition, they often undergo multiple thermo-
tropic phase transitions [8]. These transitions maybe
detected by a wide variety of physical techniques such as
DSC, dilatometry, X-ray diffraction, neutron diffraction,
dynamic light scattering, and NMR [9–11].
Experimental
Chemicals
L-a-phosphatidylcholine dipalmitoyl (1,2-dihexadecanoyl-
sn-glycerol-3-phosphocholine) 99% (DPPC), 2,4-dihy-
droxy-5-fluoropyrimidine (5-FU), 1-b-D-arabinofur-
anosylcytosine (Ara-C) were purchased from Sigma-
Aldrich Chemical Co., chloroform, dichloromethane,
hydrochloric acid, and phosphate buffered saline (buffer
PBS: K2HPO4, NaH2PO4) from POCH, Gliwice, Poland.
D2O 99%, chloroform-d 99%, stab. with Ag, dimethyl
sulfoxide (DMSO), and 4,4-dimethyl-4-silapentane sodium
sulfonate (DSS) were purchased from ARMAR Chemicals,
Switzerland.
Liposome and liposome/drug preparation
We obtained small liposomes (DPPC; DPPC/5-FU; DPPC/
Ara-C; DPPC/Ara-C/5-FU) by the modified reverse-phase
evaporation method (mREV) [12, 13]. PBS buffer pH 7.4
was applied. For 1H NMR and UV study 5 9 10-3 M 5-FU
in DMSO and 5 9 10-3 M Ara-C in D20 were added to the
preparation mixture. The preparation was carried out at
317 K. Liposome entrapped 5-FU and Ara-C were sepa-
rated from free 5-FU and free Ara-C by dialysis through
Servapor dialysis tubing against several changes of buffer
at 277 K.
NMR analysis
All spectra were obtained on 9.4 Tesla Bruker Avance
UltraShield (400.130 MHz for 1H) using a 5-mm broad
band inverse probe. 1H NMR spectra were recorded at the
temperature range 298–320 K. Temperature of the studied
samples was controlled by air and monitored by Bruker
thermal control system. The samples were heated at a rate
of about 1 K/min up and were left at this temperature for
approximately 20 min to attain the equilibrium condition
which was monitored by the invariability of the free
induction decay (FID) signal. The temperature was main-
tained at ±0.1 K. For water suppression, the presaturation
method was used. 32 transients were accumulated with a
1H pulse length of 10.70 ls pulse and 5 s relaxation delay,
2.044 s acquisition time, 32768 date points, and 0.30-Hz
line broadening. 1H chemical shift values were referred to
DSS as external reference.
Spectra processing was performed with TOPSPIN 2.1
Bruker software. Apparaturs error was ?0.01 ppm.
UV analysis
UV spectra of all prepared liposomes DPPC, DPPC/5-FU,
DPPC/Ara-C, and DPPC/Ara-C/5-FU and drugs 5-FU and
Ara-C were recorded on spectrophotometer LAMBDA
BIO 40 PERKIN ELMER using the quartz cells
1.0 9 0.5 9 4.0 cm. The investigations were done within
the temperature range 298–320 K. Apparatus error was
±1 nm and ±0.004 for the wavelength k and absorbance
A, respectively. The spectra were recorded in the range
from 200 to 400 nm. The maximum of absorption for Ara-
C and 5-FU was determined from the obtained spectra at
k = 271 nm and k = 268 nm, respectively.
To determine the concentration of the drugs incorpo-
rated into liposome vesicles the three step dialysis in
phosphate buffered saline (PBS) were done. Each dialysis
went on for 60 min at 277 K in dialysis sack Servapor with
pore diameter 2.5 nm. The percent of the drug encapsula-
tion was determined on the basis of the calibration curves.
Results and discussions
The objective of this study was to incorporate the drugs
with amphiphilic (Ara-C) and hydrophobic (5-FU) prop-
erties into liposome vesicles, prepared by the modified
reverse-phase evaporation method (mREV). We tried to
estimate the competition between these drugs for encap-
sulation in liposome vesicles, efficiency of drug encapsu-
lation, and to estimate the temperature of phase transition
of phospholipids.
The study performed with 5-FU and Ara-C allowed us to
make a comparative analysis with the data obtained pre-
viously for 5-FU and 5-formyl-5,6,7,8-tetrahydropteroyl-L-
glutamic acid calcium salt (leucovorin; LCV) [14].
Two spectroscopic methods: proton nuclear magnetic
resonance (1H NMR) and UV were used. Both spectroscopic
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methods allowed us to investigate the formation of lipo-
some/drug systems by the analysis of the signals assigned to
each drug. Temperature of phase transition was determined
using 1H NMR spectroscopy.
Nuclear magnetic resonance study
In this study, 1H NMR technique is described that can be
used to estimate the phase transition temperature (Tc) of
phospholipid. Figure 1 shows the high-resolution 1H NMR
spectra of liposome obtained from: (a) DPPC; (b) DPPC/5-
FU; (c) DPPC/Ara-C; (d) DPPC/Ara-C/5-FU.
To estimate the temperature Tc value the sequence of
spectra for each thermally equilibrated system was used as
shown in Fig. 1.
Figure 2 shows that increase of temperature leads to a
slight increase of area of the signal of protons of methyl
groups of ammonium of phospholipids –N?(CH3)3.
Derivative of 1H NMR peak area was determined from
the signals (Fig. 1). The peak maximum (Fig. 2) showed
the phase transition temperature (Tc).
Tc obtained with this method for: DPPC; DPPC/5-FU;
DPPC/Ara-C; DPPC/Ara-C/5-FU is 315.0, 315.4, 315.1,
and 312.7 K, respectively.
The fraction of drug encapsulated liposomes depends on
the physico-chemical properties of the drugs used in mul-
tidrug therapy [14].
The most significant competition in encapsulation to
liposome has been previously observed for hydrophilic–
hydrophobic (LCV–5-FU) drugs encapsulated together
[14]. In that case, the difference in encapsulation amounted
to 10.17%, i.e. it is higher than 5.33% determined for
hydrophobic–amphiphilic (5-FU–Ara-C) pair of drugs. The
content of encapsulated drugs affected the phase transition
temperature (Tc) of phospholipids. When only hydrophobic
drug was encapsulated then Tc amounted to 315.4 K. An
addition of hydrophilic LCV did not affect markedly Tc and
it was 315.2 K. Probably, the competition between 5-FU
and LCV was significant and LCV had only slight effect on
Tc. LCV due to its physico-chemical properties can be
encapsulated only within aqueous region of liposome and it
was not incorporated into phospholipids membrane. In this
study, there was a difference when both 5-FU and Ara-C
were together introduced to liposome. Between these drugs
there was only 5.33% of difference in encapsulation to
liposome. However, the difference in phase transition
temperature Tc was more significant. Tc of phospholipids
vesicle containing only hydrophobic (5-FU) drug amounted
to 315.4 K. An addition of amphiphilic Ara-C caused a
decrease of temperature up to 312.7 K. This means that
there is a division of encapsulation site of both drugs (5-FU
and Ara-C) between the phospholipide molecules. A
simultaneous location of 5-FU and Ara-C in the membrane
affected substantially the distance between phospholipids
(i.e. packing) and their mobility. The above parameters
decide about the increase or decrease of temperature Tc of
phospholipids phase transition [14].
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Fig. 1 1NMR spectra investigating the thermal transitions in lipo-
somes obtained from (A) DPPC; (B) DPPC/5-FU; (C) DPPC/Ara-C;
(D) DPPC/Ara-C/5-FU. Variation of the NMR signal of –N?(CH3)3
with increasing temperatures.
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UV study
In this study, the effect of liposome encapsulation was
discussed. The degree of the incorporation of drug into
liposome vesicles DPPC/Ara-C DPPC/5-FU, DPPC/Ara-C/
5-FU, defined as a concentration of Ara-C and 5-FU in
phospholipide carriers, was estimated using UV spectros-
copy after dialysis.
The percent of encapsulation was determined on the
basis of the calibration curves.
We compared UV spectra of Ara-C and 5-FU incorpo-
rated together into the liposome vesicles with the spectra of
each drug incorporated separately in the temperature range
298–320 K. Temperature had no effect on the UV spectra
of Ara-C and 5-FU. However, temperature affected the
spectra of Ara-C and 5-FU incorporated together into
liposome vesicles (Fig. 3).
The encapsulation efficiency, which is a measure of the
percentage of the total compound entrapped within the
liposome, is an important parameter in liposomal
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Fig. 2 Variation of the area of
the peak assigned to –N?(CH3)3
protons of DPPC of liposome
obtained from: (A) DPPC;
(B) DPPC/5-FU; (C) DPPC/
Ara-C; (D) DPPC/Ara-C/5-FU.
Determination of Tc
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characterization. It amounted to 3.75 9 10-4 M for 5-FU
and Ara-C. In the liposome vesicles DPPC/5-FU, the per-
centage of encapsulation of 5-FU amounted to 99.17%. In
the liposomes vesicles DPPC/Ara-C, the percentage of
encapsulation of Ara-C amounts to 99.89%. DPPC/Ara-C/
5-FU liposome containing both drugs, encapsulated
93.84% of 5-FU and 96.05% of Ara-C.
One can conclude that there is only a slight influence of
5-FU on the Ara-C encapsulation in liposome vesicle. The
content of Ara-C decreased by 3.84% in liposomes DPPC/
Ara-C/5-FU in comparison with liposomes formed of
DPPC/Ara-C. Slightly higher changes were observed for
the influence of Ara-C on 5-FU. Presence of Ara-C
decreased the content of 5-FU by 5.33% in liposomes
formed of DPPC/Ara-C/5-FU in comparison with those
formed of DPPC/5-FU.
Conclusions
The encapsulation of Ara-C to DPPC liposomes did not
significantly affect the Tc value in comparison with the
reference liposomes formed from DPPC. However, phase
transition temperature Tc increased for the liposomes con-
taining 5-FU. The analysis of competition between 5-FU
and Ara-C showed that Ara-C incorporated to liposome in
a higher degree than 5-FU and affected the Tc value of
phospholipid forming liposomal membrane. Moreover, the
presence of 5- FU in combination with Ara-C–5-FU caused
a decrease of encapsulation of Ara-C and a decrease of
temperature of phase transition Tc.
One can conclude that the used spectroscopic techniques
are suitable for an estimation of the phase transition tem-
perature (Tc) of phospholipid and the percentage of
encapsulation of drugs in liposomes. The use of NMR and
UV spectroscopy in the in vitro investigations of compet-
itive drugs incorporation and their transport into liposome
vesicles can be the basis for the analysis of changes which
take place in the in vivo conditions.
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